Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06680674 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

Study acronym: DiabesityDay
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 207 participants (planned 400) · Study completion date changed from estimate of May 31, 2025 to Sep 2, 2025 · Primary completion date: Mar 18, 2025 to Mar 25, 2025 · 3 more Show 6 more changesShow less
    • Final enrollment: 207 participants (planned 400)
    • Study completion date changed from estimate of May 31, 2025 to Sep 2, 2025
    • Primary completion date: Mar 18, 2025 to Mar 25, 2025
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised at 2 of 8 sites
  2. Trial status: Not Yet Recruiting to Active, Not Recruiting Study sites: 0 to 8 · Primary completion date changed from estimate of Nov 15, 2024 to Mar 18, 2025 · Completion date: Jan 1, 2025 to May 31, 2025v2 Show 3 more changesShow less
    • Study sites: 0 to 8
    • Primary completion date changed from estimate of Nov 15, 2024 to Mar 18, 2025
    • Completion date: Jan 1, 2025 to May 31, 2025
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Medical University of Vienna
173 trials monitored
See 6 trials at risk
Diabetes
4,286 trials monitored
See 187 trials at risk
Obesity
3,560 trials monitored
See 142 trials at risk
Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays. However, the pharmacological treatment of diabesity has made significant progress in recent years. The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include: 1. to determine the prevalence of causes and duration of hospitalization 2. to investigate the treatments used 3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.
Trial Details
NCT Number NCT06680674
Lead Sponsor Medical University of Vienna
Collaborators: Hospital de Cascais Dr. José de Almeida (Portugal), Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria), Rabin Medical Center, Hospital Regional de Malaga, Charles University, Czech Republic, University Hospital Bratislava, Complejo Hospitalario de Especialidades Juan Ramón Jimenez, Medical University Innsbruck, Aristotle University Of Thessaloniki, Rostov State Medical University, Hospital Marina Baixa, Riga East Clinical University Hospital, University Hospital, Aachen, San Raffaele University Hospital, Italy, Kanuni Sultan Suleyman Training and Research Hospital
Conditions Diabetes Mellitus, Obesity
Enrollment 207 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov